Percutaneous Coronary Intervention in Heart Failure: Knowledge Gaps and Opportunities.
作者信息
Tehrani Behnam N, Damluji Abdulla A, Batchelor Wayne B
机构信息
Inova Heart and Vascular Institute, Inova Health System, Falls Church, Virginia.
Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100032. doi: 10.1016/j.jscai.2022.100032. eCollection 2022 Mar-Apr.
Abstract
摘要
相似文献
1
Percutaneous Coronary Intervention in Heart Failure: Knowledge Gaps and Opportunities.
J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100032. doi: 10.1016/j.jscai.2022.100032. eCollection 2022 Mar-Apr.
2
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease.
J Am Heart Assoc. 2021 Aug 3;10(15):e021257. doi: 10.1161/JAHA.121.021257. Epub 2021 Jul 29.
3
Association of preoperative clinical frailty and clinical outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention.
Heart Vessels. 2023 Oct;38(10):1205-1217. doi: 10.1007/s00380-023-02276-3. Epub 2023 Jun 7.
4
Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
Eur J Cardiothorac Surg. 2015 Feb;47(2):316-21; discussion 321. doi: 10.1093/ejcts/ezu131. Epub 2014 Mar 23.
5
Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions.
J Am Heart Assoc. 2019 Sep 3;8(17):e013686. doi: 10.1161/JAHA.119.013686. Epub 2019 Aug 31.
6
Coronary Dissection and Right Heart Failure Salvaged by PCI With Percutaneous Intraluminal Microaxial RV-Assist Support.
JACC Case Rep. 2021 Oct 20;3(14):1612-1616. doi: 10.1016/j.jaccas.2021.06.044.
7
Clinical outcomes of nonagenarians with acute myocardial infarction who undergo percutaneous coronary intervention.
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):488-495. doi: 10.1177/2048872620921596. Epub 2020 Apr 23.
8
Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
J Am Heart Assoc. 2018 Apr 13;7(8):e008415. doi: 10.1161/JAHA.117.008415.
9
Influencing factors of care dependence in patients with coronary heart disease after percutaneous coronary intervention-A cross-sectional study.
Nurs Open. 2023 Jan;10(1):241-251. doi: 10.1002/nop2.1299. Epub 2022 Aug 23.
10
Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):632-639. doi: 10.1177/2048872616643690. Epub 2016 Apr 11.
本文引用的文献
1
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2022 Feb 8;79(5):482-503. doi: 10.1016/j.jacc.2021.11.029.
2
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
3
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2021 Sep 28;78(13):1352-1371. doi: 10.1016/j.jacc.2021.07.042.
4
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143. doi: 10.1001/jamacardio.2021.1825.
5
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2021 May 18;77(19):2432-2447. doi: 10.1016/j.jacc.2021.03.310.
6
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease.
Catheter Cardiovasc Interv. 2020 Aug;96(2):346-362. doi: 10.1002/ccd.28994. Epub 2020 Jun 4.
7
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
8
Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.
JACC Heart Fail. 2019 Jun;7(6):493-501. doi: 10.1016/j.jchf.2019.02.014. Epub 2019 May 8.
9
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.
J Am Coll Cardiol. 2016 Aug 2;68(5):450-458. doi: 10.1016/j.jacc.2016.05.060.
10
Natural History and Implantable Cardioverter-Defibrillator Implantation After Revascularization for Stable Coronary Artery Disease With Depressed Ejection Fraction.
Clin Cardiol. 2015 Dec;38(12):715-9. doi: 10.1002/clc.22477. Epub 2015 Oct 7.
Zotero 插件